To investigate the pharmacodynamic effects of combining gefitinib and BYL719 in vivo, tumor lysates of PC-9-PIK3CA-M xenografts were collected at the final day, and were analyzed for PI3K/AKT expression by western blot and IHC. The gene discussed is PIK3CA; the disease is neoplasm.